SiMPLInext SA is a Swiss startup that focuses on advanced cell culture, with the goal of fostering industrial applicability and acceptance of in vitro testing. Their slogan "Tools to foster industrial applicability and acceptance of in vitro" encapsulates their mission perfectly. This innovative company addresses the unreliability of current conventional tissue models, offering a drop-in replacement cell culture insert that significantly enhances the reliability, relevance, reproducibility, scope, and quality of data acquired through in vitro models of biological barriers. SiMPLInext's inserts allow for better cultivation of biological barriers, quality control of their function in situ, and the collection of in situ measured data. This breakthrough enables toxicologists and drug designers to gain a deeper understanding of their biological barriers without disrupting existing processes or protocols. Founded in 2016, SiMPLInext SA operates in a unique niche within the biotech sector, focusing on improving the effectiveness and practicality of in vitro testing. Although details about their last investment and investors are currently unavailable, the potential of SiMPLInext to disrupt and advance the field of advanced cell culture is noteworthy. With its innovative approach and potential to revolutionize in vitro testing, SiMPLInext SA is a startup worth watching in the biotech industry.
No recent news or press coverage available for SiMPLInext SA.